Cargando…
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
Inhibition of JAK1 or JAK2 in human tumor cells was previously shown to increase susceptibility of these cells to NK cell lysis. In the present study, we examined the cellular mechanisms that mediate this effect in hematopoietic tumor cell lines and primary tumor cells. Incubation of tumor cells wit...
Autores principales: | Bellucci, Roberto, Martin, Allison, Bommarito, Davide, Wang, Kathy, Hansen, Steen H, Freeman, Gordon J, Ritz, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485824/ https://www.ncbi.nlm.nih.gov/pubmed/26155422 http://dx.doi.org/10.1080/2162402X.2015.1008824 |
Ejemplares similares
-
IFNγ-induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells
por: Concha-Benavente, Fernando, et al.
Publicado: (2014) -
NK cell modulation by JAK inhibition
por: Schönberg, Kathrin, et al.
Publicado: (2015) -
JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis
por: Vian, Laura, et al.
Publicado: (2019) -
P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL.
por: Durán, C., et al.
Publicado: (2022) -
Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2
por: Luo, Na, et al.
Publicado: (2018)